Kezar Life Sciences Inc (KZR)
0.8568
+0.02
(+2.18%)
USD |
NASDAQ |
May 02, 16:00
0.8579
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Enterprise Value: -128.93M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | -128.93M |
| May 01, 2024 | -130.26M |
| April 30, 2024 | -131.28M |
| April 29, 2024 | -130.31M |
| April 26, 2024 | -132.71M |
| April 25, 2024 | -133.79M |
| April 24, 2024 | -132.96M |
| April 23, 2024 | -131.17M |
| April 22, 2024 | -131.46M |
| April 19, 2024 | -133.79M |
| April 18, 2024 | -133.96M |
| April 17, 2024 | -131.85M |
| April 16, 2024 | -134.29M |
| April 15, 2024 | -132.37M |
| April 12, 2024 | -128.50M |
| April 11, 2024 | -128.90M |
| April 10, 2024 | -133.06M |
| April 09, 2024 | -130.98M |
| April 08, 2024 | -132.55M |
| April 05, 2024 | -133.24M |
| April 04, 2024 | -131.52M |
| April 03, 2024 | -128.88M |
| April 02, 2024 | -128.46M |
| April 01, 2024 | -124.32M |
| March 28, 2024 | -125.67M |
| Date | Value |
|---|---|
| March 27, 2024 | -125.56M |
| March 26, 2024 | -126.23M |
| March 25, 2024 | -124.69M |
| March 22, 2024 | -120.36M |
| March 21, 2024 | -121.05M |
| March 20, 2024 | -126.33M |
| March 19, 2024 | -127.91M |
| March 18, 2024 | -127.94M |
| March 15, 2024 | -127.24M |
| March 14, 2024 | -129.42M |
| March 13, 2024 | -125.05M |
| March 12, 2024 | -123.59M |
| March 11, 2024 | -121.86M |
| March 08, 2024 | -121.69M |
| March 07, 2024 | -118.52M |
| March 06, 2024 | -116.34M |
| March 05, 2024 | -116.34M |
| March 04, 2024 | -117.07M |
| March 01, 2024 | -116.34M |
| February 29, 2024 | -114.88M |
| February 28, 2024 | -115.61M |
| February 27, 2024 | -120.74M |
| February 26, 2024 | -126.08M |
| February 23, 2024 | -125.79M |
| February 22, 2024 | -129.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-156.05M
Minimum
Nov 10 2023
840.81M
Maximum
Mar 24 2022
121.13M
Average
99.33M
Median
Enterprise Value Benchmarks
| Accuray Inc | 254.72M |
| Tonix Pharmaceuticals Holding Corp | 1.18M |
| Acumen Pharmaceuticals Inc | -7.107M |
| NovaBay Pharmaceuticals Inc | 2.666M |
| Palatin Technologies Inc | 23.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.26M |
| Total Expenses (Quarterly) | 28.40M |
| EPS Diluted (Quarterly) | -0.44 |
| Earnings Yield | -164.6% |